Caligan Partners LP Diversified Active

CIK: 0001727492 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $520,168 (100.0% shares, 0.0% debt)

Holdings (17)

VERONA PHARMA PLC 26.1%
Value ($000) $135,900 Shares 1,436,878 Est. Cost $16.60 Unrealized
LQDA LIQUIDIA CORPORATION 19.4%
Value ($000) $101,161 Shares 8,118,892 Est. Cost $5.57 Unrealized +165.8%
EXEL EXELIXIS INC 12.9%
Value ($000) $67,247 Shares 1,525,730 Est. Cost $19.42 Unrealized +105.8%
AGIO AGIOS PHARMACEUTICALS INC 6.8%
Value ($000) $35,630 Shares 1,071,258 Est. Cost $28.94 Unrealized +4.7%
MERUS N V 6.6%
Value ($000) $34,558 Shares 656,999 Est. Cost $46.55 Unrealized
EOLS EVOLUS INC 5.9%
Value ($000) $30,780 Shares 3,341,970 Est. Cost $10.58 Unrealized -3.3%
MLYS MINERALYS THERAPEUTICS INC 5.2%
Value ($000) $27,295 Shares 2,017,352 Est. Cost $11.97 Unrealized +21.1%
RVMD REVOLUTION MEDICINES INC 4.5%
Value ($000) $23,429 Shares 636,835 Est. Cost $40.00 Unrealized -4.0%
ANIK ANIKA THERAPEUTICS INC 2.9%
Value ($000) $15,184 Shares 1,435,130 Est. Cost $25.57 Unrealized -50.7%
ABVX ABIVAX SA 2.5%
Value ($000) $12,809 Shares 1,674,400 Est. Cost $7.07 Unrealized
Y-MABS THERAPEUTICS INC 2.0%
Value ($000) $10,565 Shares 2,342,609 Est. Cost $8.13 Unrealized
RZLT REZOLUTE INC 1.3%
Value ($000) $6,882 Shares 1,543,014 Est. Cost $3.77 Unrealized -1.6%
BCRX BIOCRYST PHARMACEUTICALS INC 1.1%
Value ($000) $5,725 Shares 638,908 Est. Cost $5.90 Unrealized +57.9%
SLS SELLAS LIFE SCIENCES GROUP I 1.0%
Value ($000) $5,037 Shares 2,300,000 Est. Cost Unrealized
VERRICA PHARMACEUTICALS INC 0.9%
Value ($000) $4,898 Shares 9,239,119 Est. Cost $0.65 Unrealized
TYRA TYRA BIOSCIENCES INC 0.3%
Value ($000) $1,818 Shares 189,950 Est. Cost $9.95 Unrealized -4.5%
AURA AURA BIOSCIENCES INC 0.2%
Value ($000) $1,252 Shares 200,000 Est. Cost $5.85 Unrealized 0.0%